A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Recruiting

Phase 2

EDP-938A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Sponsor:

Enanta Pharmaceuticals, Inc

Code:

NCT05568706

Conditions

RSV Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

EDP-938

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-20. This information was provided to ClinicalTrials.gov by Enanta Pharmaceuticals, Inc on 2025-04-25.